Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
QuintilesIMS
Accenture
Johnson and Johnson
UBS
Baxter
Cerilliant
McKinsey
Chinese Patent Office

Generated: June 24, 2018

DrugPatentWatch Database Preview

VERCYTE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Vercyte, and what generic alternatives are available?

Vercyte is a drug marketed by Abbott and is included in one NDA.

The generic ingredient in VERCYTE is pipobroman. Additional details are available on the pipobroman profile page.
Summary for VERCYTE
Drug patent expirations by year for VERCYTE
Medical Subject Heading (MeSH) Categories for VERCYTE
Synonyms for VERCYTE
1, 4-Bis(3-bromopropionyl)piperazine
1,1'-(Piperazine-1,4-diyl)bis(3-bromopropan-1-one)
1,4-Bis(3-bromopropanoyl)piperazine
1,4-Bis(3-bromopropanoyl)piperazine #
1,4-Bis(3-bromopropionyl)piperazine
1,4-di(3-bromopropionyl)piperazine
3-bromo-1-[4-(3-bromopropanoyl)piperazin-1-yl]propan-1-one
3B1-006101
4CH-024671
54-91-1
6Q99RDT97R
7981AB
A 1803
A-8103
AB00052352_03
AB00052352-02
AC1L1J2T
AI3-50113
AK116464
AKOS016010321
Amedel
API0005280
AX8148270
BRN 0749866
BSPBio_002574
C07362
C10H16Br2N2O2
CAS-54-91-1
CCG-39748
CCRIS 2753
CHEBI:8242
CHEMBL1585
CS-5085
CTK5I9947
D00467
D03FNJ
DB00236
DivK1c_000799
DSSTox_CID_3485
DSSTox_GSID_23485
DSSTox_RID_77048
DTXSID7023485
GTPL7271
HE004933
HE351602
HMS1922C10
HMS2093E11
HMS502H21
HSDB 3249
HY-16398
IDI1_000799
KBio1_000799
KBio2_002207
KBio2_004775
KBio2_007343
KBio3_001794
KBioSS_002207
KS-00000GXJ
LS-110402
MFCD00866372
MolPort-003-665-507
N,N-Bis-(3-bromopropionyl)-piperazine
N,N'-Bis(3-bromopropionyl)piperazine
NCGC00095048-01
NCGC00095048-02
NCGC00095048-03
NCGC00095048-04
NCGC00095048-06
NCI60_002008
NINDS_000799
NJBFOOCLYDNZJN-UHFFFAOYSA-N
NSC 25154
NSC-25154
NSC-758461
NSC25154
NSC758461
Pharmakon1600-01503393
Piperazine, 1,4-bis(3-bromo-1-oxopropyl)-
Piperazine, 1,4-bis(3-bromopropionyl)-
Piperazine,4-bis(3-bromo-1-oxopropyl)-
Piperazine,4-bis(3-bromopropionyl)-
pipobroman
Pipobroman (JAN/USAN/INN)
Pipobroman [USAN:INN]
Pipobromanum
Pipobromanum [INN-Latin]
SCHEMBL4889
SPBio_000784
Spectrum_001727
SPECTRUM1503393
Spectrum2_000912
Spectrum3_001047
Spectrum5_001135
SR-05000001858
SR-05000001858-2
ST24036545
Tox21_111402
Tox21_111402_1
UNII-6Q99RDT97R
Vercite, Vercyte
VERCYTE (TN)
WLN: T6N DNTJ AV2E DV2E
ZINC1530753

US Patents and Regulatory Information for VERCYTE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott VERCYTE pipobroman TABLET;ORAL 016245-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abbott VERCYTE pipobroman TABLET;ORAL 016245-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Harvard Business School
Deloitte
Chinese Patent Office
Baxter
Federal Trade Commission
Merck
Express Scripts
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.